Cargando…

SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies

Monoclonal antibodies (mAbs) offer a treatment option for individuals with severe COVID-19 and are especially important in high-risk individuals where vaccination is not an option. Given the importance of understanding the evolution of resistance to mAbs by SARS-CoV-2, we reviewed the available in v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cox, MacGregor, Peacock, Thomas P., Harvey, William T., Hughes, Joseph, Wright, Derek W., Willett, Brian J., Thomson, Emma, Gupta, Ravindra K., Peacock, Sharon J., Robertson, David L., Carabelli, Alessandro M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616429/ https://www.ncbi.nlm.nih.gov/pubmed/36307535 http://dx.doi.org/10.1038/s41579-022-00809-7

Ejemplares similares

Tracking SARS-CoV-2 mutations and variants through the COG-UK-Mutation Explorer
por: Wright, Derek W, et al.
Publicado: (2022)

SARS-CoV-2 variants, spike mutations and immune escape
por: Harvey, William T., et al.
Publicado: (2021)

SARS-CoV-2 variant biology: immune escape, transmission and fitness
por: Carabelli, Alessandro M., et al.
Publicado: (2023)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
por: Davis, Chris, et al.
Publicado: (2021)

Evasion of neutralising antibodies by omicron sublineage BA.2.75
por: Sheward, Daniel J, et al.
Publicado: (2022)

Monoclonal Antibody-Based Immunofluorescence Microscopy for the Rapid Identification of Burkholderia pseudomallei in Clinical Specimens
por: Tandhavanant, Sarunporn, et al.
Publicado: (2013)

Rapid Detection of Burkholderia pseudomallei in Blood Cultures Using a Monoclonal Antibody-Based Immunofluorescent Assay
por: Chantratita, Narisara, et al.
Publicado: (2013)

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
por: Mlcochova, Petra, et al.
Publicado: (2021)

Characterization of antigenic variants of hepatitis C virus in immune evasion
por: Wang, Jane H, et al.
Publicado: (2011)

Evolutionary diversification of the trypanosome haptoglobin-haemoglobin receptor from an ancestral haemoglobin receptor
por: Lane-Serff, Harriet, et al.
Publicado: (2016)

The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa
por: He, Daihai, et al.
Publicado: (2023)

SARS-COV-2 Variants: Differences and Potential of Immune Evasion
por: Hirabara, Sandro M., et al.
Publicado: (2022)

Evasión /
por: Dardick, Matilde
Publicado: (1978)

Antimicrobial Drug–Selection Markers for Burkholderia pseudomallei and B. mallei
por: Schweizer, Herbert P., et al.
Publicado: (2008)

Microbial sequencing to improve individual and population health
por: Peacock, Sharon J, et al.
Publicado: (2014)

Next-generation pathogen genomics
por: Weinstock, George M, et al.
Publicado: (2014)

Microbiology
por: Parry, Christopher M., et al.
Publicado: (2020)

In Response
por: Peacock, Sharon, et al.
Publicado: (2011)

Plasmodium falciparum Erythrocyte Invasion: Combining Function with Immune Evasion
por: Wright, Gavin J., et al.
Publicado: (2014)

Toll-Like Receptor 4 Region Genetic Variants are Associated with Susceptibility to Melioidosis
por: West, T. Eoin, et al.
Publicado: (2011)

Inflammation, Infiltration, and Evasion—Tumor Promotion in the Aging Breast
por: Cruz-Reyes, Nicole, et al.
Publicado: (2023)

La evasión
por: Giovanni, José, 1923-
Publicado: (1961)

Role of Streptococcus pneumoniae extracellular glycosidases in immune evasion
por: Mathew, Bijina J., et al.
Publicado: (2023)

New Insights from the 7th World Melioidosis Congress 2013
por: Schweizer, Herbert P., et al.
Publicado: (2014)

Moving pathogen genomics out of the lab and into the clinic: what will it take?
por: Luheshi, Leila M., et al.
Publicado: (2015)

Changing the paradigm for hospital outbreak detection by leading with genomic surveillance of nosocomial pathogens
por: Peacock, Sharon J., et al.
Publicado: (2018)

Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
por: Ghimire, Dibya, et al.
Publicado: (2022)

The mechanisms of immune response and evasion by the main SARS-CoV-2 variants
por: Chen, Qiuli, et al.
Publicado: (2022)

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
por: Sun, Cong, et al.
Publicado: (2022)

Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants
por: Chaudhari, Armi M., et al.
Publicado: (2022)

On Compulsory Vaccination
por: MacGregor, J.
Publicado: (1873)

Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant
por: Qu, Panke, et al.
Publicado: (2022)

Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
por: Qu, Panke, et al.
Publicado: (2022)

Whole-genome sequencing to control antimicrobial resistance
por: Köser, Claudio U., et al.
Publicado: (2014)

Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
por: Patel, Anamika, et al.
Publicado: (2022)

Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
por: Patel, Anamika, et al.
Publicado: (2023)

Further Evidence of Essential Differences Between Some Chemically-induced and Virus-induced Fowl Tumours
por: Peacock, P. R., et al.
Publicado: (1953)

Epithelial Tumours in Fowls Induced by 2-Acetylaminofluorene
por: Peacock, P. R., et al.
Publicado: (1954)

Attempts to Induce Epithelial Tumours in Fowls
por: Peacock, Andree, et al.
Publicado: (1949)

Cannot write session to /tmp/vufind_sessions/sess_u3oikaf1b6n7ieoehnf67c7km4